-
Product Insights
Tay-Sachs Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Tay-Sachs Disease - Drugs In Development, 2023’, provides an overview of the Tay-Sachs Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Tay-Sachs Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Hand, Foot and Mouth Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Hand, Foot and Mouth Disease - Drugs In Development, 2023’, provides an overview of the Hand, Foot and Mouth Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hand, Foot and Mouth Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Trigeminal Neuralgia (Tic Douloureux) – Drugs In Development, 2023
Global Markets Direct’s, ‘Trigeminal Neuralgia (Tic Douloureux) - Drugs In Development, 2023’, provides an overview of the Trigeminal Neuralgia (Tic Douloureux) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Trigeminal Neuralgia (Tic Douloureux), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Globoid Cell Leukodystrophy (Krabbe Disease) – Drugs In Development, 2023
Global Markets Direct’s, ‘Globoid Cell Leukodystrophy (Krabbe Disease) - Drugs In Development, 2023’, provides an overview of the Globoid Cell Leukodystrophy (Krabbe Disease) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Globoid Cell Leukodystrophy (Krabbe Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Sickle Cell Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Sickle Cell Disease - Drugs In Development, 2023’, provides an overview of the Sickle Cell Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Sickle Cell Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...